| 0 (0%) | 10-15 12:13 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 0.03 | 1-year : | 0.04 |
| Resists | First : | 0.02 | Second : | 0.03 |
| Pivot price | 0.01 |
|||
| Supports | First : | 0.01 | Second : | 0.01 |
| MAs | MA(5) : | 0.01 |
MA(20) : | 0.01 |
| MA(100) : | 0.03 |
MA(250) : | 0.24 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 7 |
D(3) : | 8.7 |
| RSI | RSI(14): 39.5 |
|||
| 52-week | High : | 1.57 | Low : | 0.01 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ EVFM ] has closed above bottom band by 17.7%. Bollinger Bands are 61.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.02 - 0.02 | 0.02 - 0.02 |
| Low: | 0.01 - 0.01 | 0.01 - 0.01 |
| Close: | 0.02 - 0.02 | 0.02 - 0.02 |
Wed, 01 Oct 2025
1.7M UAE Women Could Benefit: Evofem's Single-Dose BV Treatment Seeks First International Approval - Stock Titan
Fri, 26 Sep 2025
Evofem Biosciences Honors World Contraception Day - WV News
Fri, 26 Sep 2025
First-Ever Hormone-Free On-Demand Birth Control: Evofem's PHEXXI Transforms Contraception Options - Stock Titan
Thu, 11 Sep 2025
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
Tue, 09 Sep 2025
Majority Support Secured: Evofem-Aditxt Women's Health Merger Heads to Critical September Vote - Stock Titan
Thu, 14 Aug 2025
Evofem's Q2 Revenue Jumps 16% as TikTok Campaign Goes Viral with 7M Views, Merger Talks Progress - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 216 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 4.4 (%) |
| Shares Short | 8,680 (K) |
| Shares Short P.Month | 17,820 (K) |
| EPS | -1.4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.76 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0.05 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.02 |
| PEG Ratio | 0 |
| Price to Book value | -0.03 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2018-01-17 |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|